These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34758835)

  • 1. The prognostic role of RBP-4 and adiponectin in patients with peripheral arterial disease undergoing lower limb endovascular revascularization.
    Kadoglou NPE; Korakas E; Karkos C; Maratou E; Kanonidis I; Plotas P; Papanas N; Moutsatsou P; Ikonomidis I; Lambadiari V
    Cardiovasc Diabetol; 2021 Nov; 20(1):221. PubMed ID: 34758835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization.
    Stone PA; Schlarb H; Campbell JE; Williams D; Thompson SN; John M; Campbell JR; AbuRahma AF
    J Vasc Surg; 2014 Sep; 60(3):652-60. PubMed ID: 24795153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between omentin-1 and major cardiovascular events after lower extremity endovascular revascularization in diabetic patients: a prospective cohort study.
    Biscetti F; Nardella E; Rando MM; Cecchini AL; Angelini F; Cina A; Iezzi R; Filipponi M; Santoliquido A; Pitocco D; Landolfi R; Flex A
    Cardiovasc Diabetol; 2020 Oct; 19(1):170. PubMed ID: 33028322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum levels of osteopontin and osteoprotegerin with adverse outcomes after endovascular revascularisation in peripheral artery disease.
    Kadoglou NPE; Kapetanios D; Korakas E; Valsami G; Tentolouris N; Papanas N; Lambadiari V; Karkos C
    Cardiovasc Diabetol; 2022 Sep; 21(1):171. PubMed ID: 36050687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal Strategy for Antiplatelet Therapy After Endovascular Revascularization for Lower Extremity Peripheral Artery Disease.
    Cho S; Lee YJ; Ko YG; Kang TS; Lim SH; Hong SJ; Ahn CM; Kim JS; Kim BK; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2019 Dec; 12(23):2359-2370. PubMed ID: 31734299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum high mobility group box-1 levels associated with cardiovascular events after lower extremity revascularization: a prospective study of a diabetic population.
    Rando MM; Biscetti F; Cecchini AL; Nardella E; Nicolazzi MA; Angelini F; Iezzi R; Eraso LH; Dimuzio PJ; Pitocco D; Gasbarrini A; Massetti M; Flex A
    Cardiovasc Diabetol; 2022 Oct; 21(1):214. PubMed ID: 36244983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sortilin levels correlate with major cardiovascular events of diabetic patients with peripheral artery disease following revascularization: a prospective study.
    Biscetti F; Nardella E; Rando MM; Cecchini AL; Bonadia N; Bruno P; Angelini F; Di Stasi C; Contegiacomo A; Santoliquido A; Pitocco D; Landolfi R; Flex A
    Cardiovasc Diabetol; 2020 Sep; 19(1):147. PubMed ID: 32977814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous vein.
    Owens CD; Kim JM; Hevelone ND; Hamdan A; Raffetto JD; Creager MA; Conte MS
    J Vasc Surg; 2010 May; 51(5):1152-9. PubMed ID: 20223619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-molecular-weight and total adiponectin levels and incident symptomatic peripheral artery disease in women: a prospective investigation.
    Ho DY; Cook NR; Britton KA; Kim E; Creager MA; Ridker PM; Pradhan AD
    Circulation; 2011 Nov; 124(21):2303-11. PubMed ID: 22025604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review and meta-analysis on the association between C-reactive protein levels and adverse limb events after revascularization in patients with peripheral arterial disease.
    Di X; Han W; Liu CW; Ni L; Zhang R
    J Vasc Surg; 2021 Jul; 74(1):317-326. PubMed ID: 33684473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein and endovascular treatment of lower limb peripheral artery disease: an independent prognostic factor.
    Bleda S; de Haro J; Varela C; Acin F
    J Endovasc Ther; 2015 Apr; 22(2):233-9. PubMed ID: 25809368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indoxyl Sulfate and Incident Peripheral Artery Disease in Hemodialysis Patients.
    Lin TY; Chou HH; Huang HL; Hung SC
    Toxins (Basel); 2020 Nov; 12(11):. PubMed ID: 33147880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum retinol-binding protein 4 as a predictor of cardiovascular events in elderly patients with chronic heart failure.
    Li XZ; Zhang KZ; Yan JJ; Wang L; Wang Y; Shen XY; Sun HX; Liu L; Zhao C; He HW; Wang LS; Gao W; Lu X
    ESC Heart Fail; 2020 Apr; 7(2):542-550. PubMed ID: 31965727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating malondialdehyde-modified low-density lipoprotein (MDA-LDL) as a novel predictor of clinical outcome after endovascular therapy in patients with peripheral artery disease (PAD).
    Takamura TA; Tsuchiya T; Oda M; Watanabe M; Saito R; Sato-Ishida R; Akao H; Kawai Y; Kitayama M; Kajinami K
    Atherosclerosis; 2017 Aug; 263():192-197. PubMed ID: 28651186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of percutaneous lower-extremity arterial interventions on endothelial function and inflammation response in patients with both type 2 diabetes and lower-extremity peripheral arterial disease.
    Du Y; Wang F; Qi H; Ding H; Hou L; Gao Q; Tan M; Liu Y; Xing N; Sun J
    Int J Clin Exp Pathol; 2015; 8(7):8115-21. PubMed ID: 26339379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of one session resistance exercise on plasma adiponectin and RBP4 concentration in trained and untrained healthy young men.
    Mansouri M; Keshtkar A; Hasani-Ranjbar S; Soleymani Far E; Tabatabaei-Malazy O; Omidfar K; Larijani B
    Endocr J; 2011; 58(10):861-8. PubMed ID: 21836369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease.
    Lambadiari V; Kadoglou NP; Stasinos V; Maratou E; Antoniadis A; Kolokathis F; Parissis J; Hatziagelaki E; Iliodromitis EK; Dimitriadis G
    Cardiovasc Diabetol; 2014 Aug; 13():121. PubMed ID: 25142320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a biomarker panel for assessing cardiovascular risk in diabetic patients with chronic limb-threatening ischemia (CLTI): a prospective study.
    Nardella E; Biscetti F; Rando MM; Cecchini AL; Nicolazzi MA; Rossini E; Angelini F; Iezzi R; Eraso LH; Dimuzio PJ; Pitocco D; Massetti M; Gasbarrini A; Flex A
    Cardiovasc Diabetol; 2023 Jun; 22(1):136. PubMed ID: 37308885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of plasma ephrinB2 levels for amputation risk following endovascular revascularization in peripheral artery disease.
    Guo P; Chen L; Yang D; Zhang L; Shu C; Li H; Zhu J; Zhou J; Li X
    PeerJ; 2024; 12():e17531. PubMed ID: 38854794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-Specific Risks of Major Cardiovascular and Limb Events in Patients With Symptomatic Peripheral Artery Disease.
    Haine A; Kavanagh S; Berger JS; Hess CN; Norgren L; Fowkes FGR; Katona BG; Mahaffey KW; Blomster JI; Patel MR; Jones WS; Rockhold FW; Hiatt WR; Baumgartner I;
    J Am Coll Cardiol; 2020 Feb; 75(6):608-617. PubMed ID: 32057375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.